[go: up one dir, main page]

DE60100855D1 - 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung - Google Patents

1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung

Info

Publication number
DE60100855D1
DE60100855D1 DE60100855T DE60100855T DE60100855D1 DE 60100855 D1 DE60100855 D1 DE 60100855D1 DE 60100855 T DE60100855 T DE 60100855T DE 60100855 T DE60100855 T DE 60100855T DE 60100855 D1 DE60100855 D1 DE 60100855D1
Authority
DE
Germany
Prior art keywords
compounds
naphthalimid
antituary
acridone
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60100855T
Other languages
English (en)
Other versions
DE60100855T2 (de
Inventor
M Cholody
Teresa Kosakowska-Cholody
J Michejda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE60100855D1 publication Critical patent/DE60100855D1/de
Application granted granted Critical
Publication of DE60100855T2 publication Critical patent/DE60100855T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60100855T 2000-03-07 2001-03-05 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung Expired - Lifetime DE60100855T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18799100P 2000-03-07 2000-03-07
US187991P 2000-03-07
PCT/US2001/007087 WO2001066545A2 (en) 2000-03-07 2001-03-05 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY

Publications (2)

Publication Number Publication Date
DE60100855D1 true DE60100855D1 (de) 2003-10-30
DE60100855T2 DE60100855T2 (de) 2004-07-15

Family

ID=22691331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60100855T Expired - Lifetime DE60100855T2 (de) 2000-03-07 2001-03-05 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung

Country Status (8)

Country Link
US (1) US6664263B2 (de)
EP (1) EP1265898B1 (de)
JP (1) JP2003525940A (de)
AT (1) ATE250603T1 (de)
AU (2) AU4005401A (de)
CA (1) CA2402446C (de)
DE (1) DE60100855T2 (de)
WO (1) WO2001066545A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL374434A1 (en) 2002-07-05 2005-10-17 Targacept, Inc. N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
CA2586320A1 (en) 2003-11-05 2005-05-19 Photobiomed Corporation Bonding tissues and cross-linking proteins with naphthalimide compounds
US6979684B1 (en) 2004-06-30 2005-12-27 Council Of Scientific And Industrial Research Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof
ATE518866T1 (de) * 2004-06-30 2011-08-15 Council Scient Ind Res Über die piperazineinheit gebundene pyrroloä2,1- cüä1,4übenzodiazepin-napthalimid-konjugate und verfahren zu deren herstellung
WO2007092436A2 (en) * 2006-02-08 2007-08-16 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory disorders, demyelinating disorders and cancers
US20080108641A1 (en) * 2006-02-08 2008-05-08 Ajami Alfred M Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
CN100364536C (zh) * 2006-03-03 2008-01-30 大连理工大学 甲基异硫脲阳离子作为连接基的脱氧核糖核酸双嵌入剂
WO2008016660A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Imidazoacridine compounds for treating leukemias
WO2008016665A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Imidazoacridine compounds for treating flt3 -mediated disorders
WO2008016661A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
CN112898301B (zh) * 2021-01-29 2022-03-08 河南大学 一种萘酰亚胺吲哚杂环化合物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104548D0 (en) 1991-03-05 1991-04-17 Cholody Wienlaw M Antineoplastic modified imidazoacridines
IL110460A (en) 1993-08-18 2001-01-11 Basf Ag Bis-naphthalimides, their preparation and pharmaceutical compositions containing them
DK0892801T3 (da) * 1996-04-12 2002-04-22 Us Gov Health & Human Serv Acridon-afledte forbindelser, der er anvendelige som antineoplastiske og antiretrovirale midler

Also Published As

Publication number Publication date
CA2402446A1 (en) 2001-09-13
US20030203916A1 (en) 2003-10-30
AU4005401A (en) 2001-09-17
WO2001066545A3 (en) 2002-02-28
EP1265898A2 (de) 2002-12-18
WO2001066545A2 (en) 2001-09-13
AU2001240054B2 (en) 2005-08-11
DE60100855T2 (de) 2004-07-15
EP1265898B1 (de) 2003-09-24
JP2003525940A (ja) 2003-09-02
US6664263B2 (en) 2003-12-16
CA2402446C (en) 2011-05-17
ATE250603T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
YU81100A (sh) Derivati 2-(purin-9-il)tetrahidrofuran-3,4 diola
WO2018141002A3 (en) DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
GB0119249D0 (en) Organic compounds
UY27834A1 (es) Compuestos de amidas de acido 3-amino-tieno(2,3-b) piiridino-2-carboxilico sustituido y procedimientos para prepararlos y sus usos.
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
RS20050864A (en) Novel pyridopyrazines and use thereof as kinase inhibitors
EA201691294A2 (ru) ГЕТЕРОАРИЛЗАМЕЩЕННЫЕ ПИРРОЛО[2,3-b]ПИРИДИНЫ И ПИРРОЛО[2,3-b]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ
EA200100954A1 (ru) Производные камптотецина, обладающие противоопухолевой активностью
BRPI0412993A (pt) inibidores da atividade da akt
WO2002028904A3 (en) Human anti-cd40 antibodies
AU2735201A (en) Pyrimidine and triazine kinase inhibitors
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
EP1633740A4 (de) Chemische verbindungen
DE60100855D1 (de) 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung
TW200716110A (en) Inhibitors of AKT activity
TW200745102A (en) Pyrido[2,3-d]pyrimidine derivatives, preparation thereof, therapeutic use thereof
TW200505917A (en) Novel pyridopyrazines and the use thereof as kinase inhibitors
SI1869038T1 (sl) Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil
TW200616615A (en) Compounds and methods for the treatment of cancer
DE60004027D1 (de) Organische-arsenverbindungen
IL138352A0 (en) Fungicidal 6-(2-halo-4-alkoxyphenyl) triazolopyrimidines
DE60330651D1 (en) C3-cyanoepothilonderivate
ECSP045477A (es) COMPUESTOS DE AMIDAS DE ÁCIDO3-AMINO-TIENO[2,3-b]PIRIDINO-2-CARBOXÍLICO SUSTITUIDOY PROCEDIMIENTOS PARA PREPARARLOS Y SUS USOS.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition